Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hologic

Hologic is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of state-of-the-art digital imaging technology for general radiography and mammography applications. Our core business units are focused on osteoporosis assessment, mammography and breast biopsy, direct-to-digital x-ray for general radiography applications and mini C-arm imaging for orthopedic applications. We are a company of individuals from varying backgrounds who share a common goal - the desire to extend women's lives through the development of technologically superior diagnostic imaging systems that will facilitate the early detection of breast cancer and osteoporosis. We are proud of the work we do every day to preserve and extend the lives of countless women throughout the world. Each year, more than one million women are diagnosed with breast cancer, while hundreds of thousands of them fall victim to this dreaded disease. In addition, osteoporosis affects more than 200 million women worldwide. The rising number of osteoporotic fractures and their associated morbidity place an increasingly heavy burden on future healthcare resources, as it is estimated that the annual cost of managing osteoporosis will be more than $15 billion. Hologic has achieved a leading market position in breast cancer and osteoporosis detection in the United States. Our market share in the European, Asian and South American markets continues to grow. The fastest growing market opportunity is in the breast cancer detection segment. Our primary objective is to capitalize on this opportunity through current and future generations of our Selenia full-field digital mammography system, while responding to the increasing demand of the digital workflow. There is nothing more important than for us to remain dedicated to the principle of applying highly sophisticated technology to medical imaging challenges, and we are committed to being an active voice and a corporate role model in promoting women's health initiatives.


Contact Details:
35 Crosby Drive
Bedford
MA
01730
United States of America
Tel:781.999.7300
Fax:
Email:investor@hologic.com
WWW:

www.hologic.com/




Loading...

Recent Publications by Hologic:

A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.
BACKGROUND: Testing for human papillomavirus (HPV) has emerged as an...
29th September, 2009
Hologic, Inc., Marlborough, J Clin Virol. 2009 Jul;45 Suppl 1:S73-7.
DOI Direct Link
Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study.
BACKGROUND: Any HPV test designed to be utilized in cervical cancer...
29th September, 2009
Hologic, Inc., J Clin Virol. 2009 Jul;45 Suppl 1:S63-72.
DOI Direct Link
Dual energy X-Ray absorptiometry body composition reference values from NHANES.
In 2008 the National Center for Health Statistics released a dual energy...
16th September, 2009
Hologic, Inc., PLoS One. 2009 Sep 15;4(9):e7038.
DOI Direct Link
Voting strategy for artifact reduction in digital breast tomosynthesis.
Artifacts are observed in digital breast tomosynthesis (DBT)...
9th December, 2006
Massachusetts General Hospital, Boston, Massachusetts 02114, USA. Med Phys. 2006 Jul;33(7):2461-71.
Emerging trends in dual energy X-ray absorptiometry.
The risk of osteoporosis and cardiovascular disease increase significantly...
27th September, 2006
Radiol Manage. 2006 Jul-Aug;28(4):50-5.

View more Hologic research publications.

Press Releases on Hologic:

BioPortfolio Logo
Reportlinker Adds Fluoroscopy and Mobile C-Arms - Global Market Opportunities 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Fluoroscopy and Mobile C-Arms - Global Market Opportunities http://www
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Global In Vitro Diagnostics Investment Opportunities, Analysis and
Reportlinker Adds Bone Densitometers - Global Trends 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Bone Densitometers - Global Trends http://www.reportlinker.com/p0164310
Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009 16th November, 2009 Hologic, Inc.
-- "Adiana System for Transcervical Sterilization: 3-Year Efficacy Results;" presented by T.L. Anderson, T.G. Vancaillie; Open Communications; 6 -- Hysteroscopy
Hologic to Present at NASDAQ OMX 23rd Investor Program in London 11th November, 2009 Hologic, Inc.
BEDFORD, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Jack Cumming, Chairman, will present at the NASDAQ OMX 23rd Investor Program in London on Tuesday,

BioNews Results for Hologic:

Lower hospital spending reduces Hologic Q4 FY09 revenue
Clinica:  Nov 13 2009 4:42PM Matching: hologic
Hologic to Present at NASDAQ OMX 23rd Investor Program in London
KSLA:  Nov 11 2009 10:26PM Matching: hologic
Conceptus to Continue Patent Infringement Suit against Adiana Permanent Contraception System
SmartBrief:  Nov 10 2009 8:41PM Matching: hologic
Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results Quarterly Revenues and Performance Exceed Guidance and ExpectationsRob Cascella Pr
Yahoo! Canada:  Nov 10 2009 4:09AM Matching: hologic
Conceptus to Continue Patent Infringement Suit against Adiana Permanent Contraception System
Yahoo! Canada:  Nov 10 2009 5:34PM Matching: hologic
Promote your company here: BioNewsCast - Press Release Distribution

View more Hologic news.

Hologic Clinical Trials:

GliaSite 1-3 Mets Study

Hologic Patents:

US Patent No.Title
6009147 X-ray bone densitometry
6294789 Radiation intensifying screen
6352512 Bone analysis apparatus and method for calibration and quality assurance of an ultrasonic bone analysis apparatus
6385283 Device and method for determining future fracture risk
6437339 Flat panel x-ray imager with gain layer

View more Hologic patents.

Hologic (HOLX) Financial information Links from Barchart

HOLX Quote from from Barchart.com
HOLX Chart from from Barchart.com
HOLX Profile from from Barchart.com
HOLX Opinion from from Barchart.com

View more Hologic finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 972 times since April 2007, the link to the organisation's website has been followed 115 times

Recent Search Terms used to find this page: hologic contact | DigitalNow Hologic | hologic inc. patent | hologic inc. patent | hologic inc. patent | contacf details for hologic Inc | contacf details for hologic Inc | contacf details for hologic Inc | contacf details for hologic Inc | hologic patents | .

Search for more companies in Bedford

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Hologic

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.